Skip to content
AnalystLens

Fortive 8-K Report, Financial Results (Oct 28, 2026)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 28, 2026
Period End
October 28, 2026
Security
FTV
In the record · 2016–202610-K1010-Q328-K120

FTV filed 10 annual reports (10-K), 32 quarterly reports (10-Q) and 120 current reports (8-K) between 2016 and 2026.

  1. Change in control8-K · Jul ’16Jul ’16
  2. Deal closed8-K · Jun ’19Jun ’19
  3. Leadership change8-K · Jan ’22Jan ’22
  4. Leadership change8-K · Oct ’25Oct ’25

Summary

Summary of the 8-K filed October 28, 2026. Cited figures are marked; the original filing is the authoritative source.

Fortive Corporation reported third-quarter 2026 results for the quarter ended October 2, 2026, in a press release furnished as Exhibit 99.1 under Item 2.02.

Revenue was $1.11 billiona, up 7.8% year-over-year on a reported basis and 7.2% on a core basis. GAAP net earnings were $173 million, up 47.4%, and GAAP diluted EPS was $0.57, up 62.9%. Adjusted diluted EPS was $0.77, up 13.2%, and adjusted EBITDA was $339 million, up 9.5%, at a 30.6% margin.

Operating cash flow was $313 millionb and free cash flow was $284 million, with trailing twelve-month free cash flow of $1,062 million. The company raised its FY 2026 adjusted diluted EPS guidance to $3.10 to $3.14, which the filing describes as up approximately 15% year-over-year at the midpoint. Management said it deployed approximately $300 million toward share repurchases in the quarter, about 5 million shares or 2% of diluted shares outstanding.

Since the launch of new Fortive, total repurchases reached approximately $2.3 billionc, or about 43 million shares, representing approximately 13% of shares outstanding. By segment, Intelligent Operating Solutions revenue was $767 million, up 9.8% reported and 9.1% core, with a 35.8% adjusted EBITDA margin.

Advanced Healthcare Solutions revenue was $340 milliond, up 3.7% reported and 3.1% core, but its GAAP operating margin fell to 11.2% from 12.9%, and its adjusted EBITDA margin declined to 25.8% from 28.1%. Q3 2025 GAAP results included discontinued operations tied to the June 2025 separation of Ralliant Corporation, and GAAP results this quarter benefited from $18.0 million in pretax IEEPA tariff refunds, which the company excluded from its adjusted measures.

Key Highlights

  1. Q3 revenue of $1.11 billion grew 7.8% reported and 7.2% core; Intelligent Operating Solutions grew 9.8% reported and Advanced Healthcare Solutions grew 3.7% reported.
  2. GAAP diluted EPS of $0.57 rose 62.9% year-over-year; adjusted diluted EPS of $0.77 rose 13.2%.
  3. Adjusted EBITDA of $339 million rose 9.5%, with an adjusted EBITDA margin of 30.6%, up from 30.1%.
  4. FY 2026 adjusted diluted EPS guidance was raised to $3.10 to $3.14, described as up approximately 15% at the midpoint.
  5. Share repurchases of approximately $300 million in Q3 brought total repurchases since the launch of new Fortive to approximately $2.3 billion, or about 13% of shares outstanding.
  6. Free cash flow was $284 million in Q3 and $1,062 million on a trailing twelve-month basis; long-term debt rose to $3,514.2 million from $2,306.5 million at December 31, 2025.
  7. Advanced Healthcare Solutions margins contracted, with GAAP operating margin of 11.2% versus 12.9% and adjusted EBITDA margin of 25.8% versus 28.1%.

Frequently Asked Questions

  1. How did Fortive perform in the third quarter of 2026?

    Revenue was $1.11 billion, up 7.8% reported and 7.2% core. GAAP net earnings were $173 million, up 47.4%, and adjusted EBITDA was $339 million, up 9.5%, with a 30.6% margin.

  2. Did Fortive change its full-year outlook?

    Yes. The company raised its FY 2026 adjusted diluted EPS guidance to $3.10 to $3.14, which the filing describes as up approximately 15% year-over-year at the midpoint.

  3. How much capital did Fortive return to shareholders?

    The company deployed approximately $300 million on share repurchases in Q3 2026, about 5 million shares or 2% of diluted shares outstanding. Since the launch of new Fortive, total repurchases are approximately $2.3 billion, or about 43 million shares, representing approximately 13% of shares outstanding.

  4. Which segment showed weaker profitability?

    Advanced Healthcare Solutions. Its revenue rose 3.7% reported to $340 million, but its GAAP operating margin fell to 11.2% from 12.9%, and its adjusted EBITDA margin fell to 25.8% from 28.1%. Intelligent Operating Solutions grew revenue 9.8% to $767 million, with a 35.8% adjusted EBITDA margin.

  5. Did one-time items affect the quarter's GAAP results?

    Yes. The filing reports $18.0 million in pretax IEEPA tariff refunds, which Fortive excluded from its adjusted measures. It also excluded amortization of acquisition-related intangible assets of $89.3 million and a $6.2 million pretax capitalized software impairment.